Welcome
Support Centre
26 July 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Efficacy of movement control exercises versus general exercises on recurrent sub acute non specific low back pain in a sub group of patients with movement control dysfunction
ISRCTN ISRCTN48684087
DOI 10.1186/ISRCTN48684087
ClinicalTrials.gov identifier
EudraCT number
Public title Efficacy of movement control exercises versus general exercises on recurrent sub acute non specific low back pain in a sub group of patients with movement control dysfunction
Scientific title Efficacy of movement control exercises versus general exercises on recurrent sub-acute non specific low back pain in a sub-group of patients with movement control dysfunction: protocol of a randomized controlled trial
Acronym N/A
Serial number at source N/A
Study hypothesis Do patients within a sub-group of movement control dysfunction profit more through a specific individually tailored exercise program than through general exercise?
Lay summary Lay summary under review 1
Ethics approval Ethics Committee of Carea (Kymenlaakso Hospital District) Finland, 17 May 2010
Study design Randomised single-blind placebo-controlled cross-over study
Countries of recruitment Finland
Disease/condition/study domain Movement Control Dysfunction within recurrent sub-acute LBP
Participants - inclusion criteria 1. The aim of the "rest" inclusion regimen is to sub-classify those patients who have movement dysfunction (MD). The inclusion criteria involves three questionnaires and physical examination. Within the results of the questionnaires the participant should score:
1.1. Roland-Morris Disability Questionnaire to be > 5 points
1.2. DEPS < 12 points, Tampa Scale for Kinesiophobia < 38 points
1.3. Motor Control Abilities Questionnaire < 80 points
The Motor Control Abilities Questionnaire (MCAQ) is a self report tool that was developed to screen people for their ability to learn specific motor control stability exercise and specific movement control exercise. Reliability and validity have been established. A cut off point of 80 has a specificity of 0.98 and a sensitivity of 0.88. The MCAQ should be used to exclude those subjects who are unable to learn the exercises and thus not benefit from the treatment.
2. Within the physical examination the participant should have > 2/6 positive movement control dysfunction test described by Luomajoki et al and not to have Straight Leg Raise (SLR) under 50 degrees positive or any positive sacroiliac-joint pain provocation tests to be eligible to participate in the study. Clinical assessment should indicate that the subject is suitable for active exercise, which is asked within a questionnaire.
Participants - exclusion criteria 1. Neurological signs (leg weakness)
2. Specific spinal pathology (e.g. malignancy, or inflammatory joint or bone disease)
3. Have undergone back surgery
4. The aim of the measurement of DEPS, TSK and MCAQ is to rule out those patients with LBP of non-mechanical origin, e.g. depression, fear-avoidance and a poor ability to learn exercises
5. The aim of physical examination of SLR and sacroiliac-joint provocation tests is to rule out those patients with mechanical movement impairment
Anticipated start date 01/10/2010
Anticipated end date 31/12/2013
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 70
Interventions There will be approximately 35 participants in each group (movement control exercises versus general exercises). A physical therapist carries out an initial assessment of each participant allocated to the each exercise group to determine how physically active the participant is, how troublesome the back problem is, and the ability of the participant to perform the exercises. These are measured by the treating physiotherapist by asking the participant. Participants are then taught the exercises and advise of the intensity at which they should exercise. The exercises are performed under supervision of a physical therapist. The intensity of the exercises is progressed over the 5 treatments with participants being encouraged to improve their own performance. Each session lasts 45 minutes and includes a short session (10-15 minutes) of manual therapy.
Primary outcome measure(s) Roland-Morris Disability Questionnaire measured at baseline, after the three months intervention and finally twelve months after the start.
Secondary outcome measure(s) 1. Patient-Specific Functional and Pain Scale (PSFS)
2. Oswestry Disability Index
3. Movement control tests described by Luomajoki et al.
4. The amount of absence from work with a questionnaire
5. The need for other treatment modalities with a questionnaire
6. The need for pain medication with a questionnaire
7. Patient satisfactory with global assessment with a questionnaire
Measured at baseline, after the three months intervention and finally twelve months after the start.
Sources of funding 1. Kela The Social Insurance Institution of Finland (Finland)
2. Finnish Cultural Foundation (Finland)
Trial website
Publications 1. 2012 protocol in http://www.ncbi.nlm.nih.gov/pubmed/22494776
Contact name Mr  Vesa  Lehtola
  Address Allintie 8
  City/town Kotka
  Zip/Postcode 48220
  Country Finland
  Tel +35 844 556 0865
  Email vesa.lehtola@omt.org
Sponsor Kela The Social Insurance Institution of Finland (Finland)
  Address Kela, PL 20
  City/town Helsinki
  Zip/Postcode 00232
  Country Finland
  Email tutkimus@kela.fi
  Sponsor website: http://www.kela.fi
Date applied 04/12/2011
Last edited 19/09/2012
Date ISRCTN assigned 18/01/2012
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.